Canada’s Jamp Creates Dedicated Biosimilars Division

As It Prepares To Launch Alvotech’s Higher-Strength Adalimumab Humira Rival

 
• By Dave Wallace
  
Montreal skyline sunrise photo dawn
Montreal-based Jamp welcomes a new dawn for its biosimilars business • Source: James Byrne / Alamy Stock Photo

More from Strategy

More from Business